The rising prevalence of dementia in the population continues to pose a serious public health challenge in both the developed and the developing world. Previous editions of Dementia have become acknowledged as a key 'gold standard' work in this field, and have had a genuinely international approach. The third edition has been fully revised and updated to reflect the most recent advances in the rapidly developing field of dementia research, adding further important detail to this already authoritative and detailed text. New material on mild cognitive impairment has been included, and the latest developments in areas such as service development and carer research are also covered. All the chapters have been revised to include the most up-to-date research in their field. This is an essential work of reference for specialists in old age psychiatry, neurology, and health care of the elderly. It should also be a useful resource for others working with patients with dementia, including general practitioners, nurses, psychologists, and other allied health professionals.

Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Detailed case studies facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.

A Must-Have Resource for Clinicians, Instructors, and Students in Training! Written by internationally recognized experts, Cognitive Communication Disorders of MCI and Dementia, Third Edition provides professionals and students the most up-to-date research on the clinical assessment and management of individuals with dementia and those with mild cognitive impairment (MCI), the fastest growing clinical population. Dr. Kimberly McCullough, an expert on MCI and cognitive stimulation, joined Bayles and Tomoeda as co-author and this edition has an increased coverage of MCI, its characteristic features, the diagnostic criteria for its diagnosis, and treatment options. Students and practicing professionals will appreciate the authors' overview of the relation of cognition to communicative function and the characterization of how both are affected in MCI and the common dementia-related diseases including Alzheimer's, Lewy Body, Vascular, Parkinson's, Huntington's, Frontotemporal and Down Syndrome. A summary of important points at the end of chapters highlights essential clinical information and guides student learning. An all-new Clinical Guide comprises the second half of the book providing an extensive discussion of the process of assessment and evidence-based treatments for individuals in all stages of dementia. Features of the New Clinical Practice Guide Assessment: The authors provide a step-by-step discussion of the assessment process, an overview of reputable tests, and how to differentiate cognitive-communication disorders associated with MCI and dementing diseases. Treatment: This section includes comprehensive and detailed instructions for implementing evidence-based interventions for individuals in all stages of dementia. Additional topics include: A person-centered model for successful interventionCognitive stimulation programming for MCIClinical techniques supported by the principles of neuroplasticityIndirect interventions that facilitate communication, quality of life, and the safety of individuals with dementiaCaregiver counselingCare planning, goal setting, reimbursement and required documentation Case Examples: Includes restorative and functional maintenance plans. Cognitive-Communication Disorders of MCI and Dementia: Definition, Assessment, and Clinical Management was written by individuals dedicated to the study and treatment of cognitive-communicative disorders associated with dementia. Their research has received support by the NIH, the Alzheimer's and Related Disorders Association, the Andrus Foundation, as well as the University of Arizona, Appalachian State University and the University of Central Arkansas.

A comprehensive survey of dysfunction due to stroke, this revised edition remains the definitive guide to stroke patterns and syndromes.

Part of the authoritative Oxford Textbooks in Psychiatry series, Oxford Textbook of Old Age Psychiatry, Third Edition has been thoroughly updated to reflect the developments in old age psychiatry since publication of the Second Edition in 2013, and remains an essential reference for anyone interested in the mental health care of older people.

Dementia represents a major public health challenge for the world with over 100 million people likely to be affected by 2050. A large body of professionals is active in diagnosing, treating, and caring for people with dementia, and research is expanding. Many of these specialists find it hard to keep up to date in all aspects of dementia. This book helps solve that problem. The new edition has been updated and revised to reflect recent advances in this fast-moving field.

Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of neurology, neuroscience, geriatric medicine and endocrinology. - Presents a comprehensive overview that details the relationship between diabetes, dementia and the future of medicine and therapeutics - Written for researchers and clinicians in neurology, neuroscience, geriatric medicine and endocrinology - Includes topics ranging from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment, prevention strategies and therapeutic applications